[Actinomycosis].
Böhringer
R
R
Medizinische Poliklinik, Universitätsklinikum Bonn, Wilhelmstrasse 35-37, D-53111 Bonn. E-Mail: b.weisser@uni-bonn.de
Krautmacher
C
C
Vetter
H
H
Weisser
B
B
D000197:Actinomycosis, Cervicofacial / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000601:surgery; D000293:Adolescent; D000328:Adult; D000368:Aged; D000667:Ampicillin / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000627:therapeutic use; D019818:Clavulanic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D002981:Clindamycin / Q000008:administration & dosage / Q000627:therapeutic use; D005839:Gentamicins / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011379:Prognosis; D012008:Recurrence; D013997:Time Factors; D014057:Tomography, X-Ray Computed
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D019818:Clavulanic Acid; D002981:Clindamycin; D002939:Ciprofloxacin; D000667:Ampicillin